(Q36154808)

12 August 2017

Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models (English)

1 reference

12 August 2017

Yasuyuki Kihara

1

1 reference

12 August 2017

Aran Groves

series ordinal

2

1 reference

12 August 2017

Richard R Rivera

series ordinal

3

1 reference

12 August 2017

Jerold Chun

series ordinal

4

1 reference

12 August 2017

11 September 2015

1 reference

Annals of clinical and translational neurology

12 August 2017

1 reference

12 August 2017

2

1 reference

12 August 2017

10

1 reference

12 August 2017

978-983

1 reference

B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

The Nrf2 activator tBHQ inhibits T cell activation of primary human CD4 T cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

BG-12 in multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603381

Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FACN3.251

Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression

21 January 2018

1 reference

12 December 2020

PML in a patient with lymphocytopenia treated with dimethyl fumarate

1 reference

12 December 2020

Natalizumab: immune effects and implications for therapy

1 reference

12 December 2020

PML in a patient without severe lymphocytopenia receiving dimethyl fumarate

1 reference

12 December 2020

Downregulation of VLA-4 on T cells as a marker of long term treatment response to interferon beta-1a in MS

1 reference

12 December 2020

Identifiers

DOI

10.1002/ACN3.251

1 reference

12 August 2017

1 reference

12 August 2017

1 reference